Concepedia

Raoudha Akremi

RA

Statistics

Publications

8

Citations

371

H-Index

8

Active since

2000

Affiliations

Hôpital Beaujon(Current)

Inserm

Hospices Civils de Lyon

Sorbonne Université

Bristol-Myers Squibb (France)

Raoudha Akremi is an author at Hôpital Beaujon specializing in viral hepatitis, antiviral therapy, and infectious diseases.

Publications per year

2000–2017

8

Publications

8

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

Christophe Hézode, Pascal Lebray, Victor de Lédinghen et al. · Liver International · 2017 · 79 citations · Full text

, , +16

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C

Manuela G. Neuman, Jean‐Pierre Benhamou, Izabella M. Malkiewicz et al. · Clinical Biochemistry · 2001 · 65 citations

, , +12

A new step toward standardization of serum hepatitis C Virus-RNA quantification in patients with chronic hepatitis C

Michèle Martinot‐Peignoux, Nathalie Boyer, Véronique Le Breton et al. · Hepatology · 2000 · 62 citations · Full text

, , +17

SERUM TUMOUR NECROSIS FACTOR-α AND TRANSFORMING GROWTH FACTOR-β LEVELS IN CHRONIC HEPATITIS C PATIENTS ARE IMMUNOMODULATED BY THERAPY

Manuela G. Neuman, Jean‐Pierre Benhamou, Marc Bourlière et al. · Cytokine · 2002 · 49 citations

, , +9

LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program

Christophe Hézode, Victor de Lédinghen, H. Fontaine et al. · Journal of Hepatology · 2015 · 41 citations

, , +16

1–5 of 8